Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
Open accessAbstract
Background Gut microbiota is emerging as a novel risk factor for atherothrombosis, but the predictive role of gut‐derived lipopolysaccharide ( LPS ) is unknown. We analyzed (1) the association between LPS and major adverse cardiovascular events ( MACE ) in atrial fibrillation ( AF ) and (2) its relationship with adherence to a Mediterranean diet (Med‐diet). Methods and Results This was a prospective single‐center study including 912 AF patients treated with vitamin K antagonists (3716 patient‐years). The primary end point was a composite of MACE . Baseline serum LPS , adherence to Med‐diet (n=704), and urinary excretion of 11‐dehydro‐thromboxane B 2 (TxB 2 , n=852) were investigated. Mean age was 73.5 years; 42.9% were women. A total of 187 MACE (5.0% per year) occurred: 54, 59, and 74 in the first, second, and third tertile of LPS , respectively (log‐rank test P =0.004). Log‐ LPS (hazard ratio 1.194, P =0.009), age (hazard ratio 1.083, P <0.001), and previous cerebrovascular (hazard ratio 1.634, P =0.004) and cardiac events (hazard ratio 1.822, P <0.001) were predictors of MACE . In the whole cohort, AF (versus sinus rhythm) (β 0.087, P =0.014) and low‐density lipoprotein cholesterol (β 0.069, P =0.049) were associated with circulating LPS . Furthermore, Med‐diet score (β −0.137, P <0.001) was predictive of log‐ LPS , with fruits (β −0.083, P =0.030) and legumes (β −0.120, P =0.002) negatively associated with log‐ LPS levels. Log‐ LPS and log‐TxB 2 were highly correlated (r=0.598, P <0.001). Log‐ LPS (β 0.574, P <0.001) and Med‐diet score (β −0.218, P <0.001) were significantly associated with baseline urinary excretion of TxB 2 . Conclusions In this cohort of AF patients, LPS levels were predictive of MACE and negatively affected by high adherence to Med‐diet. LPS may contribute to MACE incidence in AF by increasing platelet activation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Circulating lipopolysaccharide concentrations were predictive of major adverse cardiovascular events in a cohort of patients with atrial fibrillation.
“In a recent observational study, circulating LPS concentrations were predictive of MACE in a cohort of patients with atrial fibrillation, suggesting that endotoxin translocation impacts CVD complications27.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,638 · see citing works
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,813 · see citing works
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879 · see citing works
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,875 · see citing works
Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Mendis, S., Implementation Group: Lars C. Wallentin Coordinator (Sweden), F. F.-A. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,422 · see citing works
(2001) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2001.tb01222.x · Cited by 3,515 · see citing works
Christiane, Druml, Wolzt, & Pleiner (2001) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 3,419 · see citing works
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,402 · see citing works
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644 · see citing works
Task Force Members, Thygesen, K. A., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,536 · see citing works
Universal Definition of Myocardial Infarction: Clinical Insights
Paiva, L., Providencia, R. A., Barra, S., Dinis, P., Faustino, C., & Gonçalves, L. M. M. (2015) · Cardiology · doi:10.1159/000371739 · Cited by 2,513 · see citing works
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968 · see citing works
Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,958 · see citing works
Adherence to Mediterranean diet and health status: meta-analysis
Sofi, F., Cesari, F., Abbate, R., Gensini, G. F., & Casini, A. (2008) · BMJ · doi:10.1136/bmj.a1344 · Cited by 1,717 · see citing works
Gut microbiota dysbiosis contributes to the development of hypertension
Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., Wu, S., Liu, W., Cui, Q., Geng, B., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0222-x · Cited by 1,685 · see citing works
(2001) · PubMed Central · Cited by 1,197 · see citing works
Mancia, G., Fagard, R. H., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T. C., Cífková, R., Backer, G. D., Dominiczak, A. F., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328364ca4c · Cited by 1,187 · see citing works
Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE
McMurray, J. J. V., Abraham, W. T., Dickstein, K., Køber, L., Massie, B. M., & Krum, H. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs033 · Cited by 1,092 · see citing works
Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019 · see citing works
Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance
Saad, M. J. A., Santos, A., & Prada, P. O. (2016) · Physiology · doi:10.1152/physiol.00041.2015 · Cited by 818 · see citing works
Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia
Moreira, A. P. B., Teixeira, T. F. S., Machado, A. B. F., Pelúzio, M. D. C. G., & Alfenas, R. D. C. G. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512001213 · Cited by 654 · see citing works
Role of gut microbiota in atherosclerosis
Jonsson, A. L., & Bäckhed, F. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.183 · Cited by 647 · see citing works
Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., Huikuri, H., et al. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609 · see citing works
Li, X. S., Obeid, S., Klingenberg, R., Gencer, B., Mach, F., Räber, L., Windecker, S., Rodondi, N., Nanchen, D., Muller, O., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw582 · Cited by 479 · see citing works
Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans
Randrianarisoa, E., Lehn-Stefan, A., Wang, X., Hoene, M., Peter, A., Heinzmann, S. S., Zhao, X., Königsrainer, I., Königsrainer, A., Balletshofer, B., et al. (2016) · Scientific Reports · doi:10.1038/srep26745 · Cited by 296 · see citing works
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Catella, F., Healy, D. P., Lawson, J. A., & FitzGerald, G. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5861 · Cited by 286 · see citing works
Violi, F., Soliman, E. Z., Pignatelli, P., & Pastori, D. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003347 · Cited by 200 · see citing works
Self-citationGallego, P., Roldan, V., Marín, F., Romera, M., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0556 · Cited by 187 · see citing works
Microbiome, trimethylamine N-oxide, and cardiometabolic disease
Tang, W. H. W., & Hazen, S. L. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.007 · Cited by 160 · see citing works
Vors, C., Pineau, G., Drai, J., Meugnier, E., Pesenti, S., Laville, M., Laugerette, F., Malpuech-Brugère, C., Vidal, H., & Michalski, M.-C. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2518 · Cited by 159 · see citing works
Low‐grade endotoxemia and platelet activation in cirrhosis
Raparelli, V., Basili, S., Carnevale, R., Napoleone, L., Del Ben, M., Nocella, C., Bartimoccia, S., Lucidi, C., Talerico, G., Riggio, O., et al. (2017) · Hepatology · doi:10.1002/hep.28853 · Cited by 142 · see citing works
Self-citationIncreased intestinal permeability as a risk factor for type 2 diabetes
Cox, A. J., Zhang, P., Bowden, D. W., Devereaux, B., Davoren, P. M., Cripps, A. W., & West, N. P. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.09.004 · Cited by 138 · see citing works
Laugerette, F., Alligier, M., Bastard, J., Drai, J., Chanséaume, E., Lambert-Porcheron, S., Laville, M., Morio, B., Vidal, H., & Michalski, M. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400044 · Cited by 132 · see citing works
Inhibition of tissue-factor-mediated thrombin generation by simvastatin
Ferro, D., Basili, S., Alessandri, C., Cara, D., & Violi, F. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00291-9 · Cited by 103 · see citing works
Self-citationMahaffey, K. W., Stevens, S. R., White, H. D., Nessel, C. C., Goodman, S. G., Piccini, J. P., Patel, M. R., Becker, R. C., Halperin, J. L., Hacke, W., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht428 · Cited by 92 · see citing works
Lyte, J. M., Gabler, N. K., & Hollis, J. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0357-6 · Cited by 87 · see citing works
Serum lipopolysaccharide-binding protein as a marker of atherosclerosis
Serrano, M., Moreno‐Navarrete, J. M., Puig, J., Moreno, M., Guerra, E., Ortega, F. J., Xifra, G., Ricart, W., & Fernández‐Real, J. M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.004 · Cited by 75 · see citing works
Does Mediterranean Diet Reduce Cardiovascular Events and Oxidative Stress in Atrial Fibrillation?
Pastori, D., Carnevale, R., Bartimoccia, S., Nocella, C., Tanzilli, G., Cangemi, R., Vicario, T., Catena, M., Violi, F., & Pignatelli, P. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6326 · Cited by 55 · see citing works
Self-citationLung exposure to lipopolysaccharide causes atherosclerotic plaque destabilisation
Jaw, J. E., Tsuruta, M., Oh, Y., Schipilow, J. D., Hirano, Y., Ngan, D. A., Suda, K., Li, Y., Oh, J. Y., Moritani, K., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00972-2015 · Cited by 46 · see citing works
Pastori, D., Pignatelli, P., Farcomeni, A., Cangemi, R., Hiatt, W. R., Bartimoccia, S., Nocella, C., Vicario, T., Bucci, T., Carnevale, R., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.05.011 · Cited by 34 · see citing works
Self-citationMediterranean diet reduces thromboxane A2 production in atrial fibrillation patients
Pignatelli, P., Pastori, D., Farcomeni, A., Nocella, C., Bartimoccia, S., Vicario, T., Bucci, T., Carnevale, R., & Violi, F. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.09.011 · Cited by 30 · see citing works
Self-citationPoller, L., Keown, M., Ibrahim, S. A., Lowe, G. D. O., Moia, M., Turpie, A. G. G., Roberts, C. T., BESSELAAR, A. M. H. P. V. D., van der Meer, F. J. M., Tripodi, A., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07337.x · Cited by 30 · see citing works
Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin
Suda, K., Eom, J., Jaw, J.-E., Mui, T., Bai, N., Or, C., Ngan, D., Li, Y., Wang, X., Tsuruta, M., et al. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00158.2011 · Cited by 17 · see citing works
Lee, S., Sung, J., Kim, J., Ahn, M., Lee, H. Y., Uhm, J., Pak, H., Lee, M., Kim, J., & Joung, B. (2016) · Medicine · doi:10.1097/md.0000000000005467 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The gut microbiota at the intersection of diet and human health
Gentile, C. L., & Weir, T. L. (2018) · Science · doi:10.1126/science.aau5812 · Cited by 1,049 · see citing works
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051 · see citing works
Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
Sagris, Μ., Vardas, E. P., Theofilis, P., Antonopoulos, A. S., Oikonomou, E. K., & Tousoulis, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010006 · Cited by 408 · see citing works
Beyond gut feelings: how the gut microbiota regulates blood pressure
Marques, F. Z., Mackay, C. R., & Kaye, D. M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.120 · Cited by 400 · see citing works
Mediterranean diet and health status: Active ingredients and pharmacological mechanisms
Schwingshackl, L., Morze, J., & HOFFMANN, G. E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14778 · Cited by 393 · see citing works
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
Violi, F., Cammisotto, V., Bartimoccia, S., Pignatelli, P., Carnevale, R., & Nocella, C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00737-2 · Cited by 384 · see citing works
Self-citationImpact of Mediterranean Diet on Chronic Non-Communicable Diseases and Longevity
Dominguez, L. J., Bella, G. D., Veronese, N., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13062028 · Cited by 346 · see citing works
Zhang, Y., Zhang, S., Li, B., Luo, Y., Gong, Y., Jin, X., Zhang, J., Zhou, Y., Zhuo, X., Wang, Z., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab114 · Cited by 272 · see citing works
Zuo, K., Li, J., Li, K., Hu, C., Gao, Y., Chen, M., Hu, R., Liu, Y., Chi, H., Wang, H., et al. (2019) · GigaScience · doi:10.1093/gigascience/giz058 · Cited by 235 · see citing works
Lyu, M., Wang, Y., Fan, G., Wang, X., Xu, S.-Y., & Zhu, Y. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02146 · Cited by 193 · see citing works
Lorenzo, F. D., Castro, C. D., Silipo, A., & Molinaro, A. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz002 · Cited by 191 · see citing works
Ferro, D., Baratta, F., Pastori, D., Cocomello, N., Colantoni, A., Angelico, F., & Ben, M. D. (2020) · Nutrients · doi:10.3390/nu12092762 · Cited by 199 · see citing works
Self-citationMicrobiome-Mediated Effects of the Mediterranean Diet on Inflammation
Bailey, M. A., & Holscher, H. D. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy013 · Cited by 187 · see citing works
Mediterranean diet in the management and prevention of obesity
Dominguez, L. J., Veronese, N., Bella, G. D., Cusumano, C., Parisi, A., Tagliaferri, F., Ciriminna, S., & Barbagallo, M. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112121 · Cited by 192 · see citing works
Lipopolysaccharide and the gut microbiota: considering structural variation
Mohr, A. E., Crawford, M. S., Jasbi, P., Fessler, S. N., & Sweazea, K. L. (2022) · FEBS Letters · doi:10.1002/1873-3468.14328 · Cited by 162 · see citing works
Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications
Potrykus, M., Czaja-Stolc, S., Stankiewicz, M., Kaska, Ł., & Małgorzewicz, S. (2021) · Nutrients · doi:10.3390/nu13113839 · Cited by 146 · see citing works
Gawalko, M. M., Agbaedeng, T. A., Saljic, A., Müller, D. N., Wilck, N., Schnabel, R. B., Penders, J., Rienstra, M., Gelder, I. C. V., Jespersen, T., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab292 · Cited by 144 · see citing works
Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque
Carnevale, R., Nocella, C., Petrozza, V., Cammisotto, V., Pacini, L., Sorrentino, V., Martinelli, O., Irace, L., Sciarretta, S., Frati, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22076-4 · Cited by 125 · see citing works
Self-citationCarnevale, R., Sciarretta, S., Valenti, V., Nonno, F. D., Calvieri, C., Nocella, C., Frati, G., Forte, M., d’Amati, G., Pignataro, M. G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz893 · Cited by 125 · see citing works
Self-citationAtherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly
Violi, F., Loffredo, L., Carnevale, R., Pignatelli, P., & Pastori, D. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6963 · Cited by 121 · see citing works
Self-citationDiet-gut microbiota interactions on cardiovascular disease
Zhang, X., & Gérard, P. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.028 · Cited by 94 · see citing works
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications
Bode, D., Pronto, J. R. D., Schiattarella, G. G., & Voigt, N. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01038-6 · Cited by 95 · see citing works
Rajapakse, J., Khatiwada, S., Akon, A. C., Yu, K. L., Shen, S., & Zekry, A. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2240031 · Cited by 94 · see citing works
Kimble, R., Gouinguenet, P., Ashor, A. W., Stewart, C. J., Deighton, K., Matu, J., Griffiths, A., Malcomson, F. C., Joel, A., Houghton, D., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2057416 · Cited by 96 · see citing works
The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health: A Narrative Review
Abrignani, V., Salvo, A., Pacinella, G., & Tuttolomondo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094942 · Cited by 90 · see citing works
André, P., Laugerette, F., & Féart, C. (2019) · Nutrients · doi:10.3390/nu11081887 · Cited by 87 · see citing works
The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome
Traber, M. G., Buettner, G. R., & Bruno, R. S. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101091 · Cited by 79 · see citing works
Role of the microbiota–gut–heart axis between bile acids and cardiovascular disease
Zhang, Z., Lv, T., Wang, X., Wu, M., Zhang, R., Yang, X., Fu, Y., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116567 · Cited by 77 · see citing works
Advances in Understanding the Molecular Basis of the Mediterranean Diet Effect
Corella, D., Coltell, Ó., Macián, F., & Ordovás, J. M. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032217-020802 · Cited by 74 · see citing works
Yoshida, N., Yamashita, T., Kishino, S., Watanabe, H., Sasaki, K., Sasaki, D., Tabata, T., Sugiyama, Y., Kitamura, N., Saito, Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69983-z · Cited by 71 · see citing works
Gut microbiome and atrial fibrillation—results from a large population-based study
Palmu, J., Börschel, C. S., Ortega‐Alonso, A., Markó, L., Inouye, M., Jousilahti, P., Salido, R. A., Sanders, K., Brennan, C., Humphrey, G., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104583 · Cited by 72 · see citing works
Tousoulis, D., Guzik, T. J., Padró, T., Duncker, D. J., Luca, G. D., Eringa, E. C., Vavlukis, M., Antonopoulos, A. S., Katsimichas, T., Cenko, E., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac057 · Cited by 65 · see citing works
Contribution of Gut Microbiota to Immunological Changes in Alzheimer’s Disease
van Olst, L., Roks, S. J. M., Kamermans, A., Verhaar, B. J. H., van der Geest, A. M., Muller, M., van der Flier, W. M., & de Vries, H. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683068 · Cited by 67 · see citing works
Gut microbial composition in patients with atrial fibrillation: effects of diet and drugs
Tabata, T., Yamashita, T., Hosomi, K., Park, J., Hayashi, T., Yoshida, N., Saito, Y., Fukuzawa, K., Konishi, K., Murakami, H., et al. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01669-y · Cited by 63 · see citing works
Elevation of markers of endotoxemia in women with polycystic ovary syndrome
Banaszewska, B., Siakowska, M., Chudzicka-Strugała, I., Chang, R. J., Pawelczyk, L. A., Zwoździak, B., Spaczyński, R., & Dulęba, A. J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa194 · Cited by 60 · see citing works
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms
Mandala, A., Janssen, R., Palle, S. K., Short, K., & Friedman, J. (2020) · Nutrients · doi:10.3390/nu12103166 · Cited by 51 · see citing works
Mawhin, M., Tilly, P., Zirka, G., Charles, A., Slimani, F., Vonesch, J., Michel, J., Bäck, M., Norel, X., & Fabre, J. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy130 · Cited by 55 · see citing works
Violi, F., Pignatelli, P., Castellani, V., Carnevale, R., & Cammisotto, V. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100998 · Cited by 52 · see citing works
Self-citationMechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
de Wit, S., Glen, C., de Boer, R. A., & Lang, N. N. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac132 · Cited by 52 · see citing works
Baratta, F., Pastori, D., Bartimoccia, S., Cammisotto, V., Cocomello, N., Colantoni, A., Nocella, C., Carnevale, R., Ferro, D., Angelico, F., et al. (2020) · Nutrients · doi:10.3390/nu12061732 · Cited by 47 · see citing works
Self-citationBacterial lipopolysaccharide is associated with stroke
Hakoupian, M., Ferino, E., Jickling, G. C., Amini, H., Stamova, B. S., Ander, B. P., Alomar, N., Sharp, F. R., & Zhan, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-86083-8 · Cited by 46 · see citing works
Ticinesi, A., Nouvenne, A., Cerundolo, N., Parise, A., Mena, P. R., & Meschi, T. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02707-9 · Cited by 45 · see citing works
Gut microbiota and cardiac arrhythmia
Fan, H., Liu, X., Ren, Z., Fei, X., Luo, J., Yang, X., Xue, Y., Zhang, F., & Liang, B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1147687 · Cited by 47 · see citing works
Wang, Z., Kaplan, R. C., Burk, R. D., & Qi, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212337 · Cited by 46 · see citing works
Iron Reshapes the Gut Microbiome and Host Metabolism
Botta, A. M., Barra, N. G., Lam, N. H., Chow, S., Pantopoulos, K., Schertzer, J. D., & Sweeney, G. (2021) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2021.10.2.160 · Cited by 39 · see citing works
Gut Microbiota Dysbiosis Induced by a High-Fat Diet Increases Susceptibility to Atrial Fibrillation
Kong, B., Fu, H., Xiao, Z., Zhou, Y., Shuai, W., & Huang, H. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.08.231 · Cited by 41 · see citing works
Wang, H., Reddy, S. T., & Fogelman, A. M. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000841 · Cited by 35 · see citing works
Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis
Cheng, W., Li, S., Lee, T.-I., Lee, T., Chung, C., Kao, Y., & Chen, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9070728 · Cited by 38 · see citing works
Pano, O., Martínez‐Lapiscina, E. H., Sayón-Orea, C., Martínez‐González, M. Á., Martínez, J. A., & Sánchez‐Villegas, A. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i11.997 · Cited by 36 · see citing works
Liu, H., Wang, H., Li, Q., Wang, Y., He, Y., Li, X., Sun, C., Ergönül, Ö., Can, F., Pang, Z., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.06.005 · Cited by 34 · see citing works
Mantzorou, M., Mentzelou, M., Vasios, G. K., Kontogiorgis, C. A., Antasouras, G., Vadikolias, Κ., Psara, E., Vorvolakos, T., Poulios, E., Serdari, A., et al. (2023) · Antioxidants · doi:10.3390/antiox12050983 · Cited by 36 · see citing works
Li, K.-M., Wang, L., Wong, C. Y., Chiu, P. K., Teoh, J. Y., Kwok, H. S., Leung, S. C. H., Wong, S. H., Tsui, S. K., & Ng, C. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00360-1 · Cited by 33 · see citing works
Papadopoulos, P., Tsigalou, C., Valsamaki, P. N., Konstantinidis, T. G., Voidarou, C. C., & Bezirtzoglou, E. (2022) · Biomedicines · doi:10.3390/biomedicines10050948 · Cited by 38 · see citing works
Sardu, C., Trotta, M. C., Santella, B., D’Onofrio, N., Barbieri, M., Rizzo, M. R., Sasso, F. C., Scisciola, L., Turriziani, F., Torella, M., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108670 · Cited by 32 · see citing works
Does gut microbiota affect atrial rhythm? Causalities and speculations
Linz, D., Gawalko, M. M., Sanders, P., Penders, J., Li, N., Nattel, S., & Dobrev, D. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab467 · Cited by 32 · see citing works
Chin, Y. H., Lim, J., Kong, G., Ng, C. H., Goh, R. J. L., Muthiah, M. D., Mehta, A., Chong, B., Lin, C., Chan, K. E., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14950 · Cited by 32 · see citing works
Gut dysbiosis-derived low-grade endotoxemia: A common basis for liver and cardiovascular disease
Violi, F., Nocella, C., Bartimoccia, S., Castellani, V., Carnevale, R., Pignatelli, P., & Cammisotto, V. (2023) · Kardiologia Polska · doi:10.33963/kp.a2023.0115 · Cited by 31 · see citing works
Self-citationThrombosis and Aging: Fibrin Clot Properties and Oxidative Stress
Konieczyńska, M., Natorska, J., & Undas, A. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0365 · Cited by 31 · see citing works
Aging‐associated atrial fibrillation: A comprehensive review focusing on the potential mechanisms
Wang, M., Hou, C., Jia, F., Zhong, C., Xue, C., & Li, J. (2024) · Aging Cell · doi:10.1111/acel.14309 · Cited by 31 · see citing works
Alhajri, N., Khursheed, R., Ali, M. T., Izneid, T. A., Al-Kabbani, O., Al-Haidar, M. B., Al-Hemeiri, F., Alhashmi, M., & Pottoo, F. H. (2021) · Microorganisms · doi:10.3390/microorganisms9102013 · Cited by 33 · see citing works
The gut–heart axis: a review of gut microbiota, dysbiosis, and cardiovascular disease development
Abdulrahim, A. O., Doddapaneni, N. S. P., Salman, N., Giridharan, A., Thomas, J., Sharma, K., Abboud, E., Rochill, K., Shreelakshmi, B., Gupta, V., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002789 · Cited by 31 · see citing works
Pastori, D., Ettorre, E., Carnevale, R., Nocella, C., Bartimoccia, S., Sordo, E. D., Cammisotto, V., Violi, F., Pignatelli, P., Saliola, M., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.07.002 · Cited by 27 · see citing works
Self-citationTwo Gut Microbiota-Derived Toxins Are Closely Associated with Cardiovascular Diseases: A Review
Yamashita, T., Yoshida, N., Emoto, T., Saito, Y., & Hirata, K. (2021) · Toxins · doi:10.3390/toxins13050297 · Cited by 26 · see citing works
Effects of hawthorn seed oil on plasma cholesterol and gut microbiota
Kwek, E., Yan, C., Ding, H., Hao, W., He, Z., Liu, J., Ma, K. Y., Zhu, H., & Chen, Z. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00690-4 · Cited by 28 · see citing works
Li, N., Wang, L., Li, L., Yang, M.-Z., Wang, Q., Bai, X., Gao, F., Yuan, Y., Yu, Z., & Ren, Z. (2023) · Military Medical Research · doi:10.1186/s40779-023-00489-1 · Cited by 32 · see citing works
Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives
Yuan, L., Li, Y., Chen, M., Xue, L., Wang, J., Ding, Y., Gu, Q., Zhang, J., Zhao, H., Xie, X., et al. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13007-7 · Cited by 28 · see citing works
Wang, M., Xiong, H., Lü, L., Zhu, T., & Jiang, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2405972 · Cited by 26 · see citing works
The human gut microbiome in critical illness: disruptions, consequences, and therapeutic frontiers
Sung, J., Rajendraprasad, S. S., Philbrick, K. L., Bauer, B. A., Gajic, O., Shah, A., Laudański, K., Bakken, J., Skalski, J. H., & Karnatovskaia, L. V. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154436 · Cited by 26 · see citing works
Ginsenosides retard atherogenesis via remodelling host–microbiome metabolic homeostasis
Wang, Y., Wu, J., Hong, Y., Zhu, J., Zhang, Y., Zhang, J., Ding, C., Che, Y., Wang, G., Jiang, A., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16320 · Cited by 27 · see citing works
Florkowski, M. R., Abiona, E., Frank, K. M., & Brichacek, A. L. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1392666 · Cited by 26 · see citing works
Inflammatory Burden and Immunomodulative Therapeutics of Cardiovascular Diseases
Kao, T., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020804 · Cited by 23 · see citing works
Biccirè, F. G., Bucci, T., Menichelli, D., Cammisotto, V., Pignatelli, P., Carnevale, R., & Pastori, D. (2022) · Nutrients · doi:10.3390/nu14061260 · Cited by 25 · see citing works
Self-citationDrapkina, O. M., Yafarova, A. A., Kaburova, A. N., & Kiselev, A. R. (2022) · Biomedicines · doi:10.3390/biomedicines10082019 · Cited by 25 · see citing works
Loffredo, L., Ivanov, V., Ciobanu, N., Deseatnicova, E., Guţu, E., Mudrea, L., Ivanov, M., Nocella, C., Cammisotto, V., Orlando, F., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8109 · Cited by 25 · see citing works
Self-citationGut Microbiota in Heart Failure—The Role of Inflammation
Fountoulakis, P. N., Theofilis, P., Vlachakis, P. K., Karakasis, P., Pamporis, K., Sagris, Μ., Dimitroglou, Y., Tsioufis, P., Oikonomou, E. K., Tsioufis, K. P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13040911 · Cited by 23 · see citing works
Diet Patterns, the Gut Microbiome, and Alzheimer’s Disease
McGrattan, A., Stewart, C. J., Cassidy, A., Woodside, J. V., & McEvoy, C. T. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220205 · Cited by 22 · see citing works
Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature
Long, M. T., Ko, D., Arnold, L. M., Trinquart, L., Sherer, J. A., Keppel, S.-S., Benjamin, E. J., & Helm, R. H. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819832237 · Cited by 22 · see citing works
Aldriwesh, M. G., Alotibi, R. S., Alqurainy, N., Alrabiah, S., Arafah, A. M., Alghoribi, M. F., & Ajina, R. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2607076 · Cited by 20 · see citing works
Coronary heart disease and gut microbiota: A bibliometric and visual analysis from 2002 to 2022
Long, D., Mao, C., Zhang, X., Liu, Y., Shangguan, X., Zou, M., Zhu, Y., & Wang, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.949859 · Cited by 19 · see citing works
Blöbaum, L., Witkowski, M., Wegner, M., Lammel, S., Schencke, P.-A., Jakobs, K., Puccini, M., Reißner, D., Steffens, D., Landmesser, U., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010176 · Cited by 20 · see citing works
André, P., de Barros, J.-P. P., Merle, B. M. J., Samieri, C., Helmer, C., Delcourt, C., & Féart, C. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab126 · Cited by 19 · see citing works
Toll-like receptor 4 activation in platelets from myocardial infarction patients
Barillà, F., Cammisotto, V., Bartimoccia, S., Loffredo, L., Nocella, C., Bruno, N., Torromeo, C., Rosa, P., Viceconte, N., Pignatelli, P., et al. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.11.019 · Cited by 20 · see citing works
Self-citationNonalcoholic Fatty Liver Disease
Ding, L., Oligschlaeger, Y., Shiri‐Sverdlov, R., & Houben, T. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_352 · Cited by 21 · see citing works
Gut Microbiota and Heart, Vascular Injury
Zeng, C., & Tan, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_8 · Cited by 18 · see citing works
Li, Q., Zhang, X., Du, Y., Liu, X., Chen, G., Xiang, P., Wu, H., Liu, C., & Wang, D. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac103 · Cited by 19 · see citing works
The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites
Lu, D., Zou, X., & Zhang, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.948755 · Cited by 20 · see citing works
Human Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 28 · see citing works
Li, M., Wang, T.-L., Xiao, W., Zhao, L., & Yao, D.-X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01509 · Cited by 16 · see citing works
Mehta, V., Nagu, P., Inbaraj, B. S., Sharma, M., Parashar, A., & Sridhar, K. (2022) · Bioengineering · doi:10.3390/bioengineering9120798 · Cited by 17 · see citing works
Editorial: Gut permeability-related endotoxemia and cardiovascular disease: A new clinical challenge
Violi, F., & Nocella, C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1118625 · Cited by 16 · see citing works
Self-citationThe Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV
Peters, B. A., Burk, R. D., Kaplan, R. C., & Qi, Q. (2023) · Current HIV/AIDS Reports · doi:10.1007/s11904-023-00648-y · Cited by 16 · see citing works
Biccirè, F. G., Barillà, F., Sammartini, E., Dacierno, E. M., Tanzilli, G., & Pastori, D. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02078-z · Cited by 15 · see citing works
Self-citationAbais‐Battad, J. M., & Mattson, D. L. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00399.2017 · Cited by 14 · see citing works
Role of intestinal microbiota changes in cardiovascular diseases pathogenesis
Vh, L., Kramarova, V. N., & Melnychuk, I. O. (2019) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2019.5.179462 · Cited by 14 · see citing works
Lazebnik, L. B., & Туркина, С. В. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-194-10-5-13 · Cited by 14 · see citing works
Menichelli, D., Carnevale, R., Nocella, C., Cammisotto, V., Castellani, V., Bartimoccia, S., Frati, G., Pignatelli, P., & Pastori, D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.779503 · Cited by 14 · see citing works
Self-citationNajjar, R. S. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10070282 · Cited by 15 · see citing works
Ząbczyk, M., Kruk, A., Natorska, J., & Undas, A. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.10.020 · Cited by 13 · see citing works
The mitochondria-gut microbiota crosstalk – A novel frontier in cardiovascular diseases
Kulkarni, H. V., & Gaikwad, A. B. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177562 · Cited by 12 · see citing works
Microbial Metabolites and Cardiovascular Dysfunction: A New Era of Diagnostics and Therapy
Kumar, J. (2025) · Cells · doi:10.3390/cells14161237 · Cited by 13 · see citing works
- Authors
- Pastori, D., Carnevale, R., Nocella, C., Novo, M., Santulli, M., Cammisotto, V., Menichelli, D., Pignatelli, P., & Violi, F.
- Affiliations
- Sapienza University of Rome (IT)
- Corresponding author
- Violi, Francesco
- ORCID
- Venue
- Journal of the American Heart Association
- Published
- 2017-11-06
- Volume
- 6
- Issue
- 6
- ISSN
- 2047-9980 (ISSN-L)
- PMC
- PMC5669181
- OpenAlex
- W2623414143
- Cited by
- 182
- References
- 45
- Citations by year
- 2026: 22 · 2025: 18 · 2024: 30 · 2023: 28 · 2022: 27 · 2021: 24 · 2020: 12 · 2019: 11 · 2018: 7 · 2017: 3
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Journal of the American Heart Association (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- atrial fibrillation, major adverse cardiovascular events, Mediterranean diet adherence, gut microbiota, atherothrombosis, 11-dehydrothromboxane B2, vitamin K antagonists, Fabaceae, fruits, LDL cholesterol, cerebrovascular events, cardiac events, serum biomarkers, risk prediction, vitamin B12 deficiency, folate deficiency, vitamin K deficiency, scurvy, vitamin E deficiency, vitamin A deficiency
- MeSH terms
- Gastrointestinal Microbiome, Aged, Aged, 80 and over, Anticoagulants, Atrial Fibrillation, Bacteria, Cerebrovascular Disorders, Female, Humans, Intestines, Lipopolysaccharides, Male, Patient Compliance, Prospective Studies, Risk Factors, Rome, Time Factors, Vitamin K, Biomarkers, Platelet Activation, Treatment Outcome, Myocardial Ischemia, Diet, Mediterranean, Kaplan-Meier Estimate, Protective Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
